ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » Internal Medicine

Top Internal Medicine Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
STEVEN POSAR MD

Internal Medicine

4,363

$406K

125
82 are 65+

17%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 25%

$93
Average prescription price

Avg: $61

K.T. POTTI M.D. PC

Internal Medicine

14,518

$924K

334
244 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $61

ANTHONY DOWELL MD

Internal Medicine

3,796

$239K

95
89 are 65+

16%
patients receiving schedule two controlled substances

Avg: 6%

26%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$63
Average prescription price

Avg: $61

JAYNE CROGHAN MD

Internal Medicine

23,640

$1.52M

773
631 are 65+

16%
patients receiving schedule two controlled substances

Avg: 6%

21%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $61

LINDA STROPES MD

Internal Medicine

117,149

$7.19M

2871
2454 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $61

ALAN STEWART M.D.

Internal Medicine

14,980

$674K

406
356 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

37%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $61

MONICA BRUNELLE MD

Internal Medicine

13,268

$725K

345
296 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

25%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $61

TAMMY DURHAM DO

Internal Medicine

25,790

$1.68M

566
415 are 65+

18%
patients receiving schedule two controlled substances

Avg: 6%

29%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $61

CAMILLO MENDOZA MD

Internal Medicine

23,181

$1.38M

633
481 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

23%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $61

CHARLES CLAGETT MD

Internal Medicine

5,120

$273K

163
144 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $61

ALEXANDER GATZIMOS M.D.,JD

Internal Medicine

4,926

$518K

219
115 are 65+

25%
patients receiving schedule two controlled substances

Avg: 6%

33%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$105
Average prescription price

Avg: $61

KAREN SHIRRELL M.D.

Internal Medicine

6,532

$291K

123
112 are 65+

24%
patients receiving schedule two controlled substances

Avg: 6%

29%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $61

STEPHEN RAPPAPORT M.D.

Internal Medicine

2,912

$136K

204
183 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

23%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $61

WILLIAM PROVINCE M.D.

Internal Medicine

38,048

$2.17M

782
713 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $61

FEDERICO SALCEDO M.D.

Internal Medicine

7,582

$492K

186
125 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

23%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $61

THOMAS BARBOUR MD

Internal Medicine

27,842

$1.45M

716
606 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $61

PATRICE YATES MD

Internal Medicine

11,478

$589K

518
452 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

25%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $61

TROY QUIZ M.D.

Internal Medicine

14,311

$954K

426
309 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $61

TAMMY CHRISTENBERRY MD

Internal Medicine

2,659

$165K

123
95 are 65+

21%
patients receiving schedule two controlled substances

Avg: 6%

21%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $61

SAMANTHA WOOD D.O.

Internal Medicine

14,520

$930K

470
396 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

24%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $61

JOSE AGUSTI M.D.

Internal Medicine

11,450

$618K

493
377 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

21%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $61

TEOFILO VINLUAN M.D.

Internal Medicine

2,645

$128K

154
106 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

23%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $61

SURENDRA SHAH M.D.

Internal Medicine

20,160

$1.32M

558
405 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $61

BRIAN JACOBS M.D.

Internal Medicine

6,310

$322K

237
202 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

20%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $61

JOHN RILEY MD MPH

Internal Medicine

8,341

$402K

384
365 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $61

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank